Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001088875-17-000026
Filing Date
2017-02-06
Accepted
2017-02-06 09:13:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 myriadgenetics12312016.txt SC 13G/A 9774
  Complete submission text file 0001088875-17-000026.txt   11234
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Subject) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-48577 | Film No.: 17574168
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN
Business Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN 00441312752000
BAILLIE GIFFORD & CO (Filed by) CIK: 0001088875 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: SC 13G/A